Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.
Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.
Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.
It took 10 years of treatments for Anisha's IBD to enter remission. But it came back in 2019 — and just as she was about to start treatment, the pandemic hit.
We are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.
The perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation, promotion or advertisement for any services of Parexel, or any drugs or therapies, including those under development. Participating in clinical trials for investigational medicines offers patients potential benefits, such as access to cutting-edge treatments and expert medical care, while contributing to medical research. However, risks may include side effects, unpredictable outcomes, and time commitment. Careful assessment of these factors helps patients make informed decisions. The content of this material, including graphics, images and text, is provided for informational purposes only and does not constitute medical advice, diagnosis or treatment. Please consult your healthcare professional for medical advice. The patient advocate has provided their consent for the use and distribution of this content.
DMD weakens the muscles until the patient can't walk and greatly shortens their lifespan. There's no cure.
After multiple falls, concussions, and a broken arm, they discovered he had Duchenne muscular dystrophy, a condition diagnosed in 20,000 children globally each year.
Through clinical trials, however, Austin found treatment to slow the disease and live a better life.
Today, he's a college student, co-founder of the nonprofit One Rare, and a member of our Patient Advisory Council — helping us better meet the needs of rare disease patients.
Lives can change when you design rare disease trials with care and precision.
Become a study of choice in patient communities
Expedite startup and accelerate timelines
Satisfy global regulations to get your treatment to market safely and quickly
Find the right experts, focused on the right indications
What we do, we do
Our Experts
Our rare disease specialists collaborate to help get your treatment to patients like Austin faster.
Executive Director, Rare Disease Center of Excellence
With 10+ years of experience in rare diseases and cell and gene therapy trials, Rachel leads our global, cross-functional Center of Excellence for Rare Diseases. She supports strategies to deliver your projects effectively, ensuring the patient perspective is included every step of the way.
Executive Director, Rare Disease Center of Excellence
With 10+ years of experience in rare diseases and cell and gene therapy trials, Rachel leads our global, cross-functional Center of Excellence for Rare Diseases. She supports strategies to deliver your projects effectively, ensuring the patient perspective is included every step of the way.
"We need to develop products that meet the needs of the patient. That’s why we work so closely with them, focusing on improving their quality of life."
Our diverse rare disease experiences ensure you get the expertise you need, no matter the indication.
Our collaboration with rare disease clinical trial sites around the world allows us to accelerate study start-ups.
North America
South America
Europe
APAC
Middle East & Africa
Our field-leading genetic specialists customize your endpoints by age, genotype, and phenotype for better data.
Our global regulatory team helps keep everything running smoothly, with expertise in breakthrough therapy designations and more.
And our patient-first approach results in deeper, more relevant insights for trial design and execution.
The perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation, promotion or advertisement for any services of Parexel, or any drugs or therapies, including those under development. Participating in clinical trials for investigational medicines offers patients potential benefits, such as access to cutting-edge treatments and expert medical care, while contributing to medical research. However, risks may include side effects, unpredictable outcomes, and time commitment. Careful assessment of these factors helps patients make informed decisions. The content of this material, including graphics, images and text, is provided for informational purposes only and does not constitute medical advice, diagnosis or treatment. Please consult your healthcare professional for medical advice. The patient advocate has provided their consent for the use and distribution of this content.
